| |
-Na+
-Na, Body Fluid
-Na, Urine
-Nasal Smear for Eosinophils
-Native DNA Antibody
-Navane®
-NE Allergen Profile
-NE Allergy Screen
-Necropsy
-Neisseria gonorrhoeae, Amplified DNA Probe (GCAMP)
-Neisseria meningitides Antigen
-Nematode Identification
-Neuron Specific Enolase
-Neuronal Nuclear Autoantibody, Cerebrospinal Fluid (HUCSF)
-Neuronal Nuclear Autoantibody, Serum (HUABB)
-Neurontin®
-Neutrophil Cytoplasmic Autoantibody Profile (ANCAB)
-Neutrophil Oxidative Burst (NEUOB)
-Newborn Screening, State Mandated (PKUNS)
-Newborn Screening, Supplemental (SNSC)
-NH3
-NH4
-Nickel, Serum (NICKL)
-Nicotine Screen, Urine (NICO)
-Nipple Secretion Smears
-Nipride®
-Nitroble tetrazolium dye test
-Nitrogen Balance Study
-Nitroprusside
-Nitroprusside Reaction
-NMO Autoantibody IgG (NMOG)
-NMP22 Tumor Marker (NMP22)
-Nocardia Culture
-Nonspecific Esterase
-Norovirus PCR (NORV)
-Norpace®
-Norpramin®
-Northeast Allergen Profile
-Northeastern URD Profile
-Nortriptyline (NORT)
-NTX-Telopeptide
-Nuclear Antibody type 1 (ANNA-1)
-5 Nucleotidase (5NUC)
|
|
|
|
Print |
| Na+ |
| |
| See Sodium, Serum |
Print |
| Na, Body Fluid |
| |
| See Sodium, Body Fluid |
Print |
| Na, Urine |
| |
| See Sodium, Urine |
Print |
| Nasal Smear for Eosinophils |
| |
| See Eosinophil Smear, Nasal Smear or Sputum |
Print |
| Native DNA Antibody |
| |
| See DNA Autoantibody, Double-Stranded |
Print |
| Navane® |
| |
| See Thiothixene NBT |
| See Neutrophil Oxidative Burst |
Print |
| NE Allergen Profile |
| |
| See Allergen Profile, Northeastern Upper Respiratory Disease |
Print |
| NE Allergy Screen |
| |
| See Allergen Profile, Northeastern Upper Respiratory Disease |
Print |
| Necropsy |
| |
| See Histopathology, Autopsy |
Print |
| Neisseria gonorrhoeae, Amplified DNA Probe |
| |
| CPT: |
87591 |
| |
| Alternate Name: |
GC Amplified DNA; |
| |
| Methodology: |
GEN-PROBE® APTIMA™ Amplified DNA Probe |
| |
| Testing Schedule: |
Routine Daily, Monday-Friday |
| |
| Report Available: |
1-4 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 swab from urethra OR 1 swab from endocervical canal OR 20-30 mL initial urine stream OR ThinPrep® Liquid Pap specimen.ThinPrep® Liquid Pap specimens go directly to Cytology Registration. |
| |
| Container: |
APTIMA™ transport swab OR GEN-PROBE® APTIMA™ urine collection container |
| |
| Collection: |
•Follow instructions on collection kit package using ONLY the enclosed swab. •Endocervical sampling for N. gonorrhoeae and/or C. trachomatis: Remove excess mucus from cervical os and surrounding mucosa using the white swab provided.Discard this swab.Insert the blue swab from collection kit 1-1.5 cm into endocervical canal.Gently rotate swab clockwise for 10-30 seconds in endocervical canal to ensure adequate sampling.Withdraw swab carefully; avoid any contact with vaginal mucosa.Remove the cap from the swab specimen transport tube and immediately place the specimen collection swab into the transport tube.Carefully break the swab shaft at the scoreline; use care to avoid splashing of contents. Re-cap the swab specimen transport tube tightly. •Urethral sampling for C. trachomatis and/or N. gonorrhoeae: Patient should not have urinated for at least 1 hour prior to sampling.Insert the blue swab 2-4 cm into urethra, Gently rotate clockwise for 2-3 seconds to ensure contact with all urethral surfaces.Withdraw swab.Remove the cap from the swab specimen transport tube and immediately place the specimen collection swab into the transport tube.Carefully break the swab shaft at the scoreline; use care to avoid splashing of contents. Recap the swab specimen transport tube tightly. •Urine: Patient should not have urinated for at least 1 hour prior to specimen collection. •Direct patient to provide first-catch urine (approximately 20 to 30 mL of initial urine stream) into a clean, dry container free of any preservative.Collection of larger volumes of urine may result in specimen dilution and may reduce test sensitivity.Female patients should not cleanse labial area prior to providing specimen. •Transport tube and transfer 2 mL of urine into specimen transport tube using disposable pipette provided.The correct volume of urine has been added when the fluid level is between black fill lines on the urine specimen transport tube label. •Tightly re-cap the urine specimen transport tube. •Urine specimens must be maintained at 2 C to 30 C in urine transport tube. •ThinPrep® Liquid Pap Specimens should be collected in the routine manner.Specimens must be run within 14 days of collection. |
| |
| Special Instructions and/or Comments: |
•DO NOT use for legal specimens, rectal, conjunctival or nasopharyngeal specimens.For these specimens, submit GC Culture. •Use only for urethral, endocervical and urine specimens. •Transport at room temperature or refrigerated. |
| |
| Reference Range: |
| Negative for Neisseria gonorrhoeae by Amplified DNA Probe. |
| |
| Clinical Utility: |
| To aid in the assessment of sexually transmitted infections. |
| |
Print |
| Neisseria meningitides Antigen |
| |
| See Bacterial Antigen Profile |
Print |
| Nematode Identification |
| |
| See Parasite Identification |
Print |
| Neuron Specific Enolase |
| |
| See Enolase, Neuron-SpecificNeuronal |
Print |
| Nuclear Antibody type 1 (ANNA-1) |
| |
| See Neuronal Nuclear Autoantibody,Serum |
Print |
| Neuronal Nuclear Autoantibody, Cerebrospinal Fluid |
| |
| CPT: |
83912 |
| |
| Alternate Name: |
Anti-Hu Antibody; Hu Antibody |
| |
| Methodology: |
Western Blot (WB) and Enzyme-Linked Immunosorbent Assay (ELISA) |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
2 mL cerebrospinal fluid |
| |
| Container: |
Sterile conical tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
| Negative |
| |
| Clinical Utility: |
| Useful for aiding in the diagnosis of Huparaneoplastic syndrome |
| |
Print |
| Neuronal Nuclear Autoantibody, Serum |
| |
| CPT: |
83520 (x2), 83912 |
| |
| Alternate Name: |
Anti-Hu Antibody; Hu Antibody; Neuronal Nuclear Antibody type 1 (ANNA-1) |
| |
| Methodology: |
Western Blot (WB) and Enzyme-Linked Immunosorbent Assay (ELISA) |
| |
| Testing Schedule: |
Routine, 2 times per week |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
| Negative |
| |
| Clinical Utility: |
| Useful for aiding the diagnosis of Hu paraneoplastic syndrome |
| |
Print |
| Neurontin® |
| |
| See Gabapentin |
Print |
| Neutrophil Cytoplasmic Autoantibody Profile |
| |
| Includes: |
•PR-3 Autoantibody (cANCA) •Myeloperoxidase Autoantibody (MPO/pANCA) |
| |
| CPT: |
86021 (x2) |
| |
| Alternate Name: |
ANCA; cANCA; MPO; Myeloperoxidase Antibody; pANCA; PR3 Antibody |
| |
| Methodology: |
Enzyme-Linked Immunosorbent Assay (ELISA) |
| |
| Testing Schedule: |
Routine, 2 times per week |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL frozen serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Centrifuge, transfer to plastic aliquot tube and freeze.Once frozen, transport specimen submerged in dry ice. |
| |
| Reference Range: |
MPO •Negative <9.0 U/mL •Positive >9.0 U/mL PR3 •Negative <3.5 U/mL •Positive >3.5 U/Ml |
| |
| Clinical Utility: |
| MPO is the main target antigen for the antineutrophil cytoplasmic autoantibodies (ANCA) which give a perinuclear (P-ANCA) immunofluorescence pattern. PR-3 is the major target antigen of antineutrophil cytoplasmic autoantibodies (ANCA) which give a cytoplasmic (C-ANCA) immunofluorescence pattern. |
| |
Print |
| Neutrophil Oxidative Burst |
| |
| CPT: |
88184 |
| |
| Alternate Name: |
Chronic Granulomatous Disease Evaluation; NBT; Nitroblue tetrazolium dye test |
| |
| Methodology: |
Flow Cytometry |
| |
| Testing Schedule: |
Routine, daily |
| |
| Specimen Requirements: |
| Minimum Volume: |
5 mL whole blood |
| |
| Container: |
Green top (sodium heparin) tube |
| |
| Collection: |
NOTE A “normal control” sample (from someone unrelated to the patient) must be drawn and submitted under the same conditionsas the patient specimenContact our Referral Testing Department at 610-402-5864 for special instructions prior to obtaining specimen. |
| |
| Special Instructions and/or Comments: |
•Collect Monday-Thursday ONLY before 1400, no holidays.Specimens must arrive in the laboratory no later than 1600. •Store as whole blood in original tube at room temperature. •DO NOT centrifuge, aliquot, refrigerate or freeze. |
| |
| Reference Range: |
| Diagnosis of Chronic granulomatous disease (CGD) Identification of CGD carriers |
| |
Print |
| Newborn Screening, State Mandated |
| |
| Includes: |
•Screening for •Congenital Adrenal Hyperplasia •Congenital Hypothyroidism – TSH •Galactose – (Gal and Gal-1-P) •Galactose – Uridyl transferase •Hemoglobinopathy Screen •Maple Syrup Urine Disease (MSUD) •Phenylketonuria (PKU) |
| |
| CPT: |
84999 |
| |
| Alternate Name: |
PKU Screen; State Newborn Screen |
| |
| Methodology: |
See individual test listings. |
| |
| Testing Schedule: |
Performed between 24-48 hours after birth.Early discharge requires specimen to be collected regardless of age of newborn. |
| |
| Report Available: |
10-14 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
All four 13 mm circles on filter paper collection card completely filled and saturated with blood according to accepted protocol. |
| |
| Container: |
Filter paper collection card appropriately completed with all information required for both baby and mother. |
| |
| Collection: |
•Always obtain specimen prior to hospital discharge.If discharged before 24 hours of age, collect a new specimen at 48 hours. •Pretransfusion specimen is essential.If transfused, wait 14 days prior to obtaining specimen. Capillary blood is obtained by heel puncture and applied directly to the filter paper collection card attached to the form.All circles must be filled and saturated with blood from one side of the filter paper only. •Air dry specimen at room temperature in a horizontal position for a minimum of 2 hours, cover blood on collection card with protective end-flap, and forward specimens to laboratory in specially labeled transport envelopes. |
| |
| Special Instructions and/or Comments: |
•DO NOT submit cord blood. •Store collection kits (forms with attached specimen cards) in a cool, dry area.Protect the collection surface from contamination prior to and after saturation with capillary blood. •DO NOT expose the specimens to heat during the drying or transport envelopes. Reference RangeNormal screen. NOTE: Repeat testing may be required as appropriate.The laboratory will contact the physician of record to initiate repeat testing.Causes for repeat analysis may include abnormal screen results, inconclusive screen results, or unsatisfactory/unacceptable specimens. |
| |
Print |
| Newborn Screening, Supplemental |
| |
| Includes: |
Screening for: Acylcarnitine Profile Amino Acid Profile Biotinidase Deficiency Cystic Fibrosis Screen G6PD Deficiency |
| |
| CPT: |
82016 |
| |
| Alternate Name: |
Supplemental Newborn Screen; Supplemental Screen |
| |
| Methodology: |
See individual test listings. |
| |
| Testing Schedule: |
Performed between 24-48 hours after birth.Early discharge requires specimen to be collected regardless of age of newborn. |
| |
| Report Available: |
10-14 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
All four 13 mm circles on filter paper collection card completely filled and saturated with blood according to accepted protocol. |
| |
| Container: |
Filter paper collection card appropriately completed with all information required for both baby and mother. |
| |
| Collection: |
•Always obtain specimen prior to hospital discharge.If discharged before 24 hours of age, collect a new specimen at 48 hours. •Pretransfusion specimen is essential.If transfused, wait 14 days prior to obtaining specimen. •Capillary blood is obtained by heel puncture and applied directly to the filter paper collection card attached to the form.All circles must be filled and saturated with blood from one side of the filter paper only. •Air dry specimen at room temperature in a horizontal position for a minimum of 2 hours, cover blood on collection card with protective end-flap and forward specimens to laboratory in specially labeled transport envelopes. |
| |
| Special Instructions and/or Comments: |
•DO NOT submit cord blood. •Store collection kits (forms with attached specimen cards) in a cool, dry area.Protect the collection surface from contamination prior to and after saturation with capillary blood. •DO NOT expose the specimens to heat during the drying or transport phases. Reference RangeNormal screen. NOTE Repeat testing may be required as appropriate. The laboratory will contact the physician of record to initiate repeat testing.Causes for repeat analysis may include abnormal screen results, inconclusive screen results, or unsatisfactory/unacceptable specimens. Highly unusual results may warrant repeat testing by very specific confirmation procedures.When required the laboratory will initiate and coordinate these requests. |
| |
| Clinical Utility: |
| Useful for a screening test for many metabolic diseases in newborns. |
| |
Print |
| NH3 |
| |
| See Ammonia, Plasma |
Print |
| NH4 |
| |
| See Ammonia, Plasma |
Print |
| Nickel, Serum |
| |
| CPT: |
83885 |
| |
| Methodology: |
Inductively Coupled Plasma - Mass Spectrometry (ICP- MS) |
| |
| Testing Schedule: |
Routine, 1 time per week |
| |
| Report Available: |
7-10 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Royal Blue top trace metal tube, red label |
| |
| Collection: |
High concentrations of gadolinium and iodine are known to interfere with most metals tests. If either gadolinium or iodine containing contrast media has been administered, a specimen cannot be collected for 96 hours |
| |
| Special Instructions and/or Comments: |
•Centrifuge, pour serum into metal free, acid washed vial and freeze. • DO NOT insert a pipette into the serum to accomplish transfer. •DO NOT ream the specimen with a wooden stick. •Specimen will only be accepted in vials labeled with “metal free” labels. |
| |
| Reference Range: |
| 0.5-1.7 ng/mL |
| |
| Clinical Utility: |
| Urine nickel is the test of choice for detecting nickel toxicity in patients exposed to Ni(CO)(4) |
| |
Print |
| Nicotine Screen, Urine |
| |
| CPT: |
83887 |
| |
| Methodology: |
Thin Layer Chromatography (TLC) |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
10 mL urine |
| |
| Container: |
Plastic urine container |
| |
| Collection: |
Freshly voided random urine |
| |
| Reference Range: |
| None detected in nonsmokers. |
| |
Print |
| Nipple Secretion Smears |
| |
| See Cytopathology, Direct Smears |
Print |
| Nipride® |
| |
| See Thiocyanate |
Print |
| Nitroble tetrazolium dye test |
| |
| See Neutrophil Oxidative Burst |
Print |
| Nitrogen Balance Study |
| |
| See Urea Nitrogen, Urine |
Print |
| Nitroprusside |
| |
| See Thiocyanate |
Print |
| Nitroprusside Reaction |
| |
| See Acetone, Semiquantitative |
Print |
| NMO Autoantibody IgG |
| |
| CPT: |
86255 |
| |
| Methodology: |
Indirect Immunoflourescence (IFA) |
| |
| Testing Schedule: |
Routine, Mon. - Fri. only |
| |
| Report Available: |
7-14 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1.0 mL Serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Reference Range: |
| Negative |
| |
| Clinical Utility: |
| Useful for establishing the diagnosis of neuromylitis optica (NMO) and related disorders (eg, relapsing transverse myelitis or relapsing optic neuritis) and distingushing these disorders from multiple sclerosis early in the course of disease. This allows initiation and maintenance of optimal therapy. |
| |
Print |
| NMP22 Tumor Marker |
| |
| CPT: |
86316 |
| |
| Methodology: |
EIA |
| |
| Testing Schedule: |
Routine, once per week |
| |
| Report Available: |
3-10 days |
| |
| Special Instructions and/or Comments: |
• Collect a single void of urine between midnight and noon • Stabilize sample IMMEDIATELY using the NMP22 urine collection kit.Stabilized urine should be blue/green in color. • Refrigerate stabilized sample. |
| |
| Reference Range: |
| < 10 U/mL |
| |
| Clinical Utility: |
| Useful for diagnosing low grade bladder cancers. NMP22 appears to be more sensitive and specific for this type of tumor than cytology alone. NMP22 will be increased in patients with bladder cancinoma. |
| |
Print |
| Nocardia Culture |
| |
| See Culture, Nocardia |
Print |
| Nonspecific Esterase |
| |
| See Esterase Stain, Alpha-Naphthyl Acetate |
Print |
| Norpace® |
| |
| See Disopyramide |
Print |
| Norpramin® |
| |
| See Desipramine |
Print |
| Northeast Allergen Profile |
| |
| See Allergen Profile, Northeastern Upper Respiratory Disease |
Print |
| Northeastern URD Profile |
| |
| See Allergen Profile, Northeastern Upper Respiratory Disease |
Print |
| Nortriptyline |
| |
| CPT: |
80182 |
| |
| Alternate Name: |
Aventyl®; Pamelor® |
| |
| Methodology: |
High Pressure Liquid Chromatography (HPLC) |
| |
| Testing Schedule: |
Routine, |
| |
| Report Available: |
1-2 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
2 mL serum or plasma |
| |
| Container: |
Red top tube, no serum separator |
| |
| Collection: |
Draw immediately before next dose (minimum 12 hours after last dose) |
| |
| Reference Range: |
•Therapeutic..............70-170 ng/mL •Toxic ....................... > 500 ng/mL |
| |
| Clinical Utility: |
| Useful for Monitoring for optimal therapeutic concentration and monitoring paitent compliance. |
| |
Print |
| Norovirus PCR |
| |
| CPT: |
87798 |
| |
| Methodology: |
Real-Time RT-PCR |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
2-5 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 gram stool (minimum 0.5 grams) |
| |
| Container: |
Plastic stool container with lid OR plastic urine container, no preservative |
| |
| Special Instructions and/or Comments: |
| Freeze entire specimen. Once frozen, transport specimen submerged in dry ice. |
| |
| Reference Range: |
| Not detected |
| |
| Clinical Utility: |
| Noroviruses are a major cause of viral gastroenteritis in children and adults, with large outbreaks reported in hospitals, cruise ships, schools, and residential homes. This assay detects norovirus RNA using reverse transcription of specific conserved norovirus genomic RNA sequences followed by real-time PCR amplification |
| |
Print |
| NTX-Telopeptide |
| |
| See Collagen NTX-Telopeptide, Random Urine |
Print |
| 5 Nucleotidase |
| |
| CPT: |
83915 |
| |
| Methodology: |
Enzyme Kinetic |
| |
| Testing Schedule: |
Routine, 3 times per week |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Centrifuge, transfer to plastic aliquot tube and freeze.Once frozen, transport specimen submerged in dry ice. |
| |
| Reference Range: |
| 2.0-8.0 U/L |
| |
| Clinical Utility: |
| Determining cholestatic liver disease, particularly when GGT and ALP could be falsely elevated due to drug induction |
| |
|